# West Pharmaceutical Services, Inc. (WST) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $585M |
| 2024 | $570M |
| 2023 | $676M |
| 2022 | $734M |
| 2021 | $752M |
| 2020 | $407M |
| 2019 | $297M |
| 2018 | $240M |
| 2017 | $226M |
| 2016 | $195M |
| 2015 | $129M |
| 2014 | $182M |
| 2013 | $162M |
| 2012 | $135M |
| 2011 | $110M |
| 2010 | $91M |
| 2009 | $98M |
| 2008 | $124M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $177M |
| 2025-09-30 | $168M |
| 2025-06-30 | $154M |
| 2025-03-31 | $107M |
| 2024-09-30 | $161M |
| 2024-06-30 | $126M |
| 2024-03-31 | $123M |
| 2023-09-30 | $177M |
| 2023-06-30 | $183M |
| 2023-03-31 | $155M |
| 2022-09-30 | $186M |
| 2022-06-30 | $228M |
| 2022-03-31 | $190M |
| 2021-09-30 | $181M |
| 2021-06-30 | $211M |
| 2021-03-31 | $176M |
| 2020-09-30 | $99M |
| 2020-06-30 | $104M |
| 2020-03-31 | $88M |
| 2019-09-30 | $67M |
| 2019-06-30 | $81M |
| 2019-03-31 | $71M |
| 2018-09-30 | $61M |
| 2018-06-30 | $60M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/WST/operating-income)